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Letters to the Editor
Ischemia-Modified Albumin
and Myocardial Ischemia
Sbarouni et al. (1) reported on “Ischemia-Modified Albumin
[IMA] in Relation to Exercise Stress Testing [EST]” in a previous
issue of the Journal. Although the investigators found significant
differences in the IMA values at baseline, peak exercise, and after
EST, there was no relation between the IMA changes and the
result of the EST. The researchers stated that changes in IMA
levels do not reflect myocardial ischemia and that IMA does not
seem to improve the accuracy of EST. Although these are highly
interesting results, some important points must be considered in
this study.
Previous studies have shown that IMA is a marker of myocar-
dial ischemia, and it was accepted that IMA is an early marker to
help in ruling out patients with acute coronary syndrome (2,3).
Interestingly, Sbarouni et al. (1) concluded that IMA levels do not
indicate myocardial ischemia different from these other studies.
False negative and false positive results of exercise testing are
important clinical problems in diagnosis of coronary artery disease
(CAD). The sensitivity and specificity of EST range between 60%
and 70% (4,5). Approximately 30% to 40% more false negative
results may be obtained in clinical practice. Therefore, each
positive EST is not accepted as a sign of myocardial ischemia.
However, in the study by Sbarouni et al. (1), a positive stress test
is accepted as indicative of myocardial ischemia. It is not men-
tioned how many patients with positive EST have myocardial
ischemia. In our opinion, lack of this important information may
change the study results.
Other conflicts and controversial subjects are related to results
from postexercise IMA levels. Because plasma IMA levels increase
within minutes after myocardial ischemia, peak exercise IMA
levels may not indicate myocardial ischemia. However, postexer-
cise IMA levels may be helpful to determine myocardial ischemia
during exercise. Previously, it was demonstrated that IMA levels
decrease after physical exercise, and it was hypothesized that this
immediate decrease may have been attributable to interference in
the IMA measurement by lactate produced during skeletal muscle
ischemia (6,7) However, release of lactate after EST in patients
with peripheral vascular disease has been reported (8) Although
Sbarouni et al. (1) concluded that a decrease in IMA levels is
associated with hemoconcentration, it was unknown whether
peripheral vascular disease was present in the study population.
Therefore, possible peripheral vascular disease in patients may
affect IMA levels via increased lactate concentration.
*Nihat Kalay, MD
Yakup Cetinkaya, MD
Ibrahim Ozdogru, MD
*Department of Cardiology
Erciyes University School of Medicine
Erciyes Universitesi Tip Fakultesi Kalp Hastanesi
Talas, Kayseri 38039
Turkey
E-mail: nihatkalay@hotmail.com
doi:10.1016/j.jacc.2007.04.012
REFERENCES
1. Sbarouni E, Georgiadou P, Theodorakis GN, Kremastinos DT.
Ischemia-modified albumin in relation to exercise stress testing. J Am
Coll Cardiol 2006;48:2482–4.
2. Sinha MK, Roy D, Gaze DC, Collinson PO, Kaski JC. Role of
“ischemia modified albumin,” a new biochemical marker of myocardial
ischaemia, in the early diagnosis of acute coronary syndromes. Emerg
Med J 2004;21:29–34.
3. Anwaruddin S, Januzzi JL Jr., Baggish AL, Lewandrowski EL, Le-
wandrowski KB. Ischemia-modified albumin improves the usefulness of
standard cardiac biomarkers for the diagnosis of myocardial ischemia in
the emergency department setting. Am J Clin Pathol 2005;123:140–5.
4. Gibbons RJ, Abrams J, Gary J, et al. ACC/AHA guidelines for exercise
testing: a report of the American College of Cardiology/American
Heart Association Task Force on Practice Guidelines (Committee on
Exercise Testing). J Am Coll Cardiol 1997;30:260–311.
5. Sketch MH, Mohiuddin SM, Nair CK, Mooss AN, Runco V.
Automated and nomographic analysis of exercise tests. JAMA 1980;
243:1052–5.
6. Apple FS, Quist HE, Otto AP, Mathews WE, Murakami MM.
Release characteristics of cardiac biomarkers and ischemia modified
albumin as measured by the albumin cobalt-binding test after a
marathon race. Clin Chem 2002;48:1097–100.
7. Zapico-Muniz E, Santalo-Bel M, Merce-Muntanola J, Montiel JA,
Martinez-Rubio A, Ordonez-Llanos J. Ischemia-modified albumin
during skeletal muscle ischemia. Clin Chem 2004;50:1063–5.
8. Duprez D, De Buyzere M, Van Wassenhove A, Clement D. Evaluation
of the metabolic compensation after treadmill test in patients with
peripheral occlusive arterial disease. Angiology 1992;43:126–33.
Ischemia-Modified Albumin:
The Importance of Oxidative Stress
We read with interest the recent study by Sbarouni et al. (1) which
adds to the growing body of evidence regarding ischemia-modified
albumin (IMA). Interestingly, in their study, the IMA levels
dropped significantly at peak exercise in both patients with positive
and negative exercise stress-test responses, suggesting that the
observed changes in IMA levels may not reflect myocardial
ischemia. In addition to Sbarouni et al. (1), other investigators
have previously shown reduced IMA levels immediately after
exercise in different clinical conditions: for example, exercise-
induced skeletal muscle ischemia in patients with peripheral
vascular disease (2) and induced forearm ischemia in normal
volunteers (3). The possible explanations for the observed IMA
changes after exertion include an increase in albumin levels due to
hemoconcentration and the resultant decrease in the nonbound
portion of cobalt. It has also been suggested that this immediate
decrease in IMA concentration may be attributable to interference
with the IMA measurement by lactate produced during skeletal
muscle work or ischemia. These findings are important for 2 main
reasons: 1) they may cast doubt as to whether IMA changes are
truly representative of cardiac ischemia in patients with chest pain,
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